Healthcare software provider Veeva Systems (NASDAQ:VEEV) will be reporting earnings tomorrow after market hours. Here’s what you need to know.

Veeva Systems beat analysts’ revenue expectations by 2.2% last quarter, reporting revenues of $699.2 million, up 13.4% year on year. It was a very strong quarter for the company, with a solid beat of analysts’ EBITDA estimates and full-year EPS guidance exceeding analysts’ expectations.

Is Veeva Systems a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Veeva Systems’s revenue to grow 10.9% year on year to $699.1 million, slowing from the 11.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.58 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Veeva Systems has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.4% on average.

Looking at Veeva Systems’s peers in the vertical software segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Doximity delivered year-on-year revenue growth of 24.6%, beating analysts’ expectations by 9.6%, and Upstart reported revenues up 56.1%, topping estimates by 20.1%. Doximity traded up 35.5% following the results while Upstart was also up 31.8%.

Read our full analysis of Doximity’s results here and Upstart’s results here.

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.